Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Koehler, L.
Right arrow Articles by Zeidler, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koehler, L.
Right arrow Articles by Zeidler, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2000; 39: 360-368
© 2000 British Society for Rheumatology


Reviews

Managing seronegative spondarthritides

L. Koehler, J. G. Kuipers and H. Zeidler

Division of Rheumatology, Department of Internal Medicine, Medical School Hannover, Carl-Neuberg Strasse 1, D 30625 Hannover, Germany


    Introduction
 
Over the last several decades the classification of rheumatoid factor-negative arthritis has changed substantially. For some time it was common practice to consider psoriatic arthritis, Reiter's syndrome, and ankylosing spondylitis as ‘atypical’ or ‘special forms of rheumatoid arthritis’, as reflected in the proposed classification of rheumatic diseases by the International League Against Rheumatism in 1957 [1]. As described by Moll et al. [2] the school of ‘lumpers’, who preferred to group the so-called ‘variants of rheumatoid arthritis’ with rheumatoid arthritis itself, were overcome by the school of ‘splitters’, prompted by the idea that these seronegative arthritides were, in fact, entirely separate entities. This change was mirrored by the Nomenclature and Classification of the Rheumatic Diseases proposed by the American Rheumatism Association in 1963 [1]. Rheumatoid arthritis, juvenile Still's disease, ankylosing spondylitis, psoriatic arthritis, and Reiter's syndrome were then classified under separate headings with . . . [Full Text of this Article]


    How can we overcome the outdated classification of ‘seronegative arthritis’ by a rational, cost-effective diagnostic strategy?
 

    Which follow-up measurements are really needed for routine management?
 

    Symptom- and problem-orientated therapeutic management
 
Spinal disease
Enthesiopathy
Peripheral arthritis
Underlying chronic or persistent infections
Management of refractory spondarthritides

    Future perspectives
 

    Conclusions
 

    Acknowledgments
 

    Notes
 

    References
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?